Marbofloxacin 20 mg

Metacresol 2 mg
Disodium edetate 0.10 mg
Monothioglycerol 0.50 mg

Target Species

Calves (pre-ruminant and ruminant), pigs, dogs and cats.

Indications for use, specifying the target species

Treatment of infections due to marbofloxacin susceptible strains of bacteria.

In Calves
Treatment of respiratory infections caused by Histophilus somni, Mannheimia haemolytica and Pasteurella multocida.

In Pigs
Treatment of respiratory infections.
Treatment of Metritis Mastitis Agalactia (MMA) syndrome.

In Dogs
Treatment of infected wounds and abscesses.
Treatment of lower urinary tract infections due to Escherichia coli and Proteus mirabilis.
Prevention of surgical infections due to Staphylococcus intermedius, Escherichia coli and Pseudomonas aeruginosa.

In Cats
Treatment of infected wounds and abscesses.
Prevention of surgical infections due to Staphylococcus intermedius, Escherichia coli and Pseudomonas aeruginosa.

View Product Information